EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor

Nadezhda S Dyrkheeva iD, Anastasia A Malakhova iD, Aleksandra L Zakharenko, Larisa S Okorokova, Dmitriy N Shtokalo, Sophia V Pavlova iD, Sergey P Medvedev iD, Suren M Zakian, Anna A Nushtaeva iD, Alexey E Tupikin, Marsel R Kabilov iD, Svetlana N Khodyreva und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nadezhda S Dyrkheeva und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 8 Lavrentyeva Ave., 630090 Novosibirsk, R…. Hauptthemen laut MEDLINE: Phosphoric Diester Hydrolases, Topotecan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Russian state-funded project for ICBFM SB RAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topoisomerase 1 (TOP1) is an enzyme that regulates DNA topology and is essential for replication, recombination, and other processes. The normal TOP1 catalytic cycle involves the formation of a short-lived covalent complex with the 3′ end of DNA (TOP1 cleavage complex, TOP1cc), which can be stabilized, resulting in cell death. This fact substantiates the effectiveness of anticancer drugs—TOP1 poisons, such as topotecan, that block the relegation of DNA and fix TOP1cc. Tyrosyl-DNA phosphodiesterase 1 (TDP1) is able to eliminate TOP1cc. Thus, TDP1 interferes with the action of topotecan. Poly(ADP-ribose) polymerase 1 (PARP1) is a key regulator of many processes in the cell, such as maintaining the integrity of the genome, regulation of the cell cycle, cell death, and others. PARP1 also controls the repair of TOP1cc. We performed a transcriptomic analysis of wild type and PARP1 knockout HEK293A cells treated with topotecan and TDP1 inhibitor OL9-119 alone and in combination. The largest number of differentially expressed genes (DEGs, about 4000 both up- and down-regulated genes) was found in knockout cells. Topotecan and OL9-119 treatment elicited significantly fewer DEGs in WT cells and negligible DEGs in PARP1-KO cells. A significant part of the changes caused by PARP1-KO affected the synthesis and processing of proteins. Differences under the action of treatment with TOP1 or TDP1 inhibitors alone were found in the signaling pathways for the development of cancer, DNA repair, and the proteasome. The drug combination resulted in DEGs in the ribosome, proteasome, spliceosome, and oxidative phosphorylation pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphoric Diester HydrolasesTopotecanCRISPR-Cas SystemsDNADNA RepairDNA Topoisomerases, Type IEsterasesProteasome Endopeptidase ComplexTranscriptomePoly (ADP-Ribose) Polymerase-1

Stichwörter der Autor:innen

DMSODNA repairHEK293APARP1 knockoutTDP1 inhibitorpoly(ADP-ribose) polymerase 1topoisomerase 1topotecantranscriptometyrosyl-DNA phosphodiesterase 1

Substanzen

DNADNA Topoisomerases, Type IEsterasesPhosphoric Diester HydrolasesProteasome Endopeptidase ComplexTopotecanPoly (ADP-Ribose) Polymerase-1

Autor:innen und Institutionen

  • Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 8 Lavrentyeva Ave., 630090 Novosibirsk, Russia.
  • Federal Research Centre Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, 10 Lavrentyeva Ave., 630090 Novosibirsk, Russia.
  • AcademGene LLC, 6 Lavrentyeva Ave., 630090 Novosibirsk, Russia.
  • A.P. Ershov Institute of Informatics Systems SB RAS, 6 Lavrentyeva Ave., 630090 Novosibirsk, Russia.
  • N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9 Lavrentyeva Ave., 630090 Novosibirsk, Russia.
  • Department of Molecular Biology and Biotechnology, Novosibirsk State University, 630090 Novosibirsk, Russia.

ORCID-Profile: Nadezhda S Dyrkheeva, Anastasia A Malakhova, Sophia V Pavlova, Sergey P Medvedev, Anna A Nushtaeva, Marsel R Kabilov, Olga A Luzina, Olga I Lavrik

Förderung

  • Russian Science Foundation
  • Russian state-funded project for ICBFM SB RAS

Zitieren

APA

Dyrkheeva, N. S., Malakhova, A. A., Zakharenko, A. L., Okorokova, L. S., Shtokalo, D. N., Pavlova, S. V., Medvedev, S. P., Zakian, S. M., Nushtaeva, A. A., Tupikin, A. E., Kabilov, M. R., Khodyreva, S. N., Luzina, O. A., Salakhutdinov, N. F., & Lavrik, O. I. (2023). Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065148

Vancouver

Dyrkheeva NS, Malakhova AA, Zakharenko AL, Okorokova LS, Shtokalo DN, Pavlova SV, et al. Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065148

BibTeX
@article{Dyrkheeva2023,
  author = {Dyrkheeva, Nadezhda S and Malakhova, Anastasia A and Zakharenko, Aleksandra L and Okorokova, Larisa S and Shtokalo, Dmitriy N and Pavlova, Sophia V and Medvedev, Sergey P and Zakian, Suren M and Nushtaeva, Anna A and Tupikin, Alexey E and Kabilov, Marsel R and Khodyreva, Svetlana N and Luzina, Olga A and Salakhutdinov, Nariman F and Lavrik, Olga I},
  title = {Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065148}
}
Kostenlos starten →